Search Results

Roadmaps bend toward what sounds fundable instead of what creates durable value. 👉 Over time, the company It is whether decision-making remains anchored in a clear strategic framework before, during, and after

Bias agonism pitfalls  that emerge during translation.

Even compounds with pristine target profiles can fail in vivo due to poor absorption, limited tissue In the late 20th century, nearly half of investigational drugs failed due to inadequate PK. encounter hepatic metabolism—primarily driven by cytochrome P450 enzymes —which governs clearance and duration

Useful people create progress when milestones slip or dissolve entirely. 4️⃣ Emotional stability during Useful people remain constructive during these phases instead of becoming defensive or disengaged. 👉

It starts by noticing what grabs your attention, what sparks those quiet “aha” moments during a lecture

6️⃣ Long-term viability signals: Does your data hint at durability, repeatability, or translatability

These optimizations enabled dual-color labeling strategies, surface-selective imaging, and ultimately What made the collaboration durable wasn’t simply aligned expertise.

From GLP-1 and GIP dual agonists to the growing field of GPCR-based delivery systems, collaboration will

Here’s how it happens: 1️⃣ Duplicated effort 👉 Two teams think they’re building toward the same milestone

The real pivot came during clinical rotations. How do we prevent lean muscle loss during weight loss?

In the full lecture, you will learn how to extract affinity even in this dual-behavior scenario: Focus

The Monash model flipped that logic: Shared infrastructure, not duplicated equipment Centralized core What mattered was how leadership leveraged luck into durable structure  — through funding strategies,

. • The Power of Structure : How privileged scaffolds and rational design open the door to dual activity

Kenakin highlights how hybrid molecules  — combining two pharmacophores into one scaffold — enable dual-modality

This dual perspective makes Carlsson a trusted partner for industry teams navigating early-stage pipelines

However, Trinquet’s team, in collaboration with Professor David Parker from Durham University, cracked

peripheral metabolism and systemic energy homeostasis Eiken syndrome with parathyroid hormone resistance due

silent advantage of many successful drugs: they bind tightly or covalently , making target coverage durable irreversible mechanisms are designed, not discovered by accident , they become strategic levers: Selective, durable

Tom Sakmar, Emily Lorenzen, and Ilana Kotliar about creating a multiplex system with DUET-tagged constructs

article GPCR Publication Highlights   GLP-1R/GIPR biased agonism enhances metabolic outcomes —with dual

Dual control: not just brightness but fluorescence lifetime, with drastic shifts as pH drops. Tag-lite development 🧪 Mid-2010s: Rare-earth scaffold work begins 🔬 2023: pHSense probes optimized for dual It’s the product of layered collaborations—with Durham University chemist David Parker on the probe chemistry

In this session, you’ll gain: ✅ A clear map of how drugs interact with enzymes before, during, and after

But a pattern emerged: some scaffolds showed dual responsiveness to pH through lifetime and brightness Mini Timeline: The Road to pHSense → Initial lanthanide probe design with Durham University (chemistry ) → Discovery of pH-sensitive dual response (brightness + lifetime) → Application to GPCR models with Revnity’s partnership with Durham (chemistry) and the Institute of Functional Genomics in Montpellier

If your team is arguing about “potency vs. effect size vs. duration,” this is your playbook for aligning Working closely with Professor David Parker of Durham University, Trinquet’s group cracked the scaffold

A new contributor article from our friends at Celtrays Research outlines how dual-labeled fluorescent Dual-label specificity blocks promiscuous ligand confusion Lanthanide donors + d2 acceptors = high SNR

Dobutamine’s dual action on beta and alpha receptors, for example, invites reflex bradycardia that blunts

GPCR and global experts at the GPCR Drug Discovery session during Discovery on Target 2025—where groundbreaking

Transform Flow Cytometry in GPCR Analysis GPCRs are a tough target in traditional antibody staining due

The turning point came during her master’s program in pharmacogenomics.

A GPCR program can collapse—not because of bad science, but because brilliant teams are forced into duct